keyword
https://read.qxmd.com/read/38389040/semiquantitative-18-f-fdg-pet-ct-in-monitoring-glucocorticoid-response-of-immunoglobulin-g4-related-effusive-constrictive-pericarditis-a-case-report
#21
JOURNAL ARTICLE
Soo Yeon An, Byung Joo Sun
BACKGROUND: Immunoglobulin G4 (IgG4)-related effusive constrictive pericarditis (ECP) is a rare manifestation of IgG4-related disease (IgG4-RD). It can lead to persistent pericardial fibrosis, resulting in cardiac tamponade, diastolic dysfunction, and heart failure. Glucocorticoids are the primary treatment for effectively reducing inflammation and preventing fibrosis. However, guidelines for monitoring treatment response are lacking and tapering glucocorticoid therapy for specific target organs remains a challenge...
February 22, 2024: BMC Cardiovascular Disorders
https://read.qxmd.com/read/38361809/assessing-the-hazard-of-death-cardiac-tamponade-and-pericardial-constriction-among-hiv-and-tuberculosis-pericarditis-patients-using-the-extended-cox-hazard-model-intervention-study
#22
JOURNAL ARTICLE
Abdul-Karim Iddrisu, Dominic Otoo, Afa Kwasi, Freedom Gumedze
BACKGROUND AND AIMS: Tuberculous (TB) pericarditis (TBP), a TB of the heart, is linked to significant morbidity and mortality rates. Administering glucocorticoid therapy to individuals with TBP might enhance overall results and lower the likelihood of fatality. However, the actual clinical effectiveness of supplementary glucocorticoids remains uncertain. This study specifically evaluated the effects of prednisolone, prednisolone-antiretroviral therapy (ART) interaction, and other potential risk factors in reducing the hazard of the composite outcome, death, cardiac tamponade, and constriction, among TBP and human immunodeficiency virus (HIV) patients...
February 2024: Health Science Reports
https://read.qxmd.com/read/38348404/pericardiectomy-for-constrictive-pericarditis-with-or-without-cardiopulmonary-bypass
#23
REVIEW
Jing-Bin Huang, Yun-Tian Tang
AIM: We aim to access the effect of pericardiectomy for constrictive pericarditis with or without cardiopulmonary bypass. METHODS: This was a review of pericardiectomy for constrictive pericarditis. RESULTS: Cardiopulmonary bypass is actually an important maneuver to attain complete relief of the constriction. The short additional time of cardiopulmonary bypass during the procedure has very little effect on the risk of morbidity of the main operation...
2024: Vascular Health and Risk Management
https://read.qxmd.com/read/38347560/the-clinical-value-of-p-wave-terminal-force-in-lead-v1-in-evaluating-pericardial-thickness-in-tuberculous-constrictive-pericarditis
#24
JOURNAL ARTICLE
Yanhong Ren
AIM: To investigate the relationship between p wave terminal force (Ptfv1) and pericardial thickness in patients with tuberculous constrictive pericarditis. METHODS: From January 2018 to October 2022, 95 patients with tuberculous constrictive pericarditis who needed pericarditis dissection in a hospital were collected, and 3 patients who did not meet the criteria were excluded, a total of 92 cases. The absolute value of Ptfv1 in conventional electrocardiogram was tested before surgery, and pericardial thickness was measured by echocardiography and chest CT...
February 12, 2024: Journal of Cardiothoracic Surgery
https://read.qxmd.com/read/38344416/a-classical-case-report-of-constrictive-pericarditis-highlighting-the-role-of-magnetic-resonance-imaging-and-haemodynamic-assessment
#25
Paulina M Conradi, Josephine F Heidendael, Carolien M H B Lucas, Mehrdad Talebian Yazdi, M Louis Handoko
BACKGROUND: Constrictive pericarditis is a rare complication of pericarditis and is difficult to diagnose due to non-specific presentation. It mostly presents with right-sided heart failure as a consequence of a rigid pericardium that encases the heart causing impaired diastolic filling. CASE SUMMARY: We present the case of a patient with signs and symptoms of dyspnoea and right-sided heart failure who was initially diagnosed with heart failure with preserved ejection fraction (HFpEF) but remained symptomatic despite being euvolaemic after treatment...
February 2024: European Heart Journal. Case Reports
https://read.qxmd.com/read/38321789/pericardiectomy-and-mechanical-mitro-aortic-valve-replacement-in-a-young-patient-with-erdheim-chester-disease
#26
JOURNAL ARTICLE
Nerea Lopez Perez, Mathieu van Steenberghe, Jörg D Seebach, Philippe Meyer, Johannes Alexander Lobrinus, Christoph Huber, Mustafa Cikirikcioglu
Erdheim-Chester disease is a rare histiocytosis that primarily affects the skeletal system, but cardiovascular manifestations occur in 75% of cases and are associated with a poor prognosis. Given the small number of cases, the evolution and management of the disease are uncertain. Therefore, it is important to report and share Erdheim-Chester cases. This report presents the case of a young patient with constrictive pericarditis and mitral valve regurgitation resulting from Erdheim-Chester disease.
February 7, 2024: Texas Heart Institute Journal
https://read.qxmd.com/read/38318721/diagnostic-procedure-for-localized-constrictive-pericarditis-leading-to-bilateral-pleural-effusion-two-case-reports
#27
Shaowei Liu, Zhi Li, Naijian Li, Weifeng Wei, Xinyin Liang, Jinlin Wang
Constrictive pericarditis is a rare disease. Localized constrictive pericarditis leading to bilateral pleural effusion is more difficult to recognize, and the diagnostic procedure can be ambiguous. Here, we report two patients diagnosed with localized constrictive pericarditis who presented with bilateral pleural effusion. A thorough work-up showed that the pleural effusion was nonspecific, as was the pathology of the pleura. One patient had a history of pericardial effusion 2 years ago, and the other had undergone surgery for an anterior mediastinum teratoma...
February 6, 2024: ESC Heart Failure
https://read.qxmd.com/read/38313324/calcific-constrictive-pericarditis-following-tumour-necrosis-factor-alpha-inhibition
#28
Brian Cunneen, Hafiz Hussein, Jenna O'Sullivan, Ibrahim Yearoo
BACKGROUND: Tumour necrosis factor (TNF)-alpha inhibition is a core therapeutic avenue for a broad range of inflammatory and autoimmune disorders including rheumatoid arthritis and inflammatory bowel disease, as well as dermatological conditions such as hidradenitis suppurativa. Adalimumab has become one of the most common TNF-alpha-inhibiting agents, which is used for many of these conditions. Treatment with such agents is associated with numerous systemic side effects, though cardiac complications remain relatively rare...
February 2024: European Heart Journal. Case Reports
https://read.qxmd.com/read/38230271/clinical-significance-of-preoperative-pyrazinamide-containing-therapy-in-tuberculous-constrictive-pericarditis
#29
JOURNAL ARTICLE
Likui Fang, Wenfeng Yu, Guocan Yu, Gang Chen, Bo Ye
BACKGROUND: Tuberculous constrictive pericarditis (TCP) is recommended to be treated with anti-tuberculosis (TB) therapy before pericardiectomy. Whether different preoperative anti-TB regimens may lead to different outcomes is unclear. METHODS: We retrospectively collected patients diagnosed as TCP and received pericardiectomy from April 2016 to June 2023. The study patients were assigned into the active TCP (A-TCP) group and the inactive TCP (IA-TCP) group according to the results of Mycobacterium tuberculosis (MTB) culture and MTB RNA assay...
2024: Infection and Drug Resistance
https://read.qxmd.com/read/38204553/not-so-transient-effusive-constrictive-pericarditis
#30
JOURNAL ARTICLE
Muhammad Majid, Zachary S Yaker, Chad Brands, Shinya Unai, Allan L Klein
A 63-year-old male patient presented with chest pain and signs of volume overload. His work-up revealed a diagnosis of transient effusive constrictive pericarditis of idiopathic etiology. Despite treatment with optimal medical therapy, he continued to experience persistent symptoms eventually requiring radical pericardiectomy.
December 20, 2023: JACC. Case reports
https://read.qxmd.com/read/38204543/milk-of-calcium-causing-a-case-of-calcific-pericardial-effusion
#31
JOURNAL ARTICLE
Justin N Durland, Ethan D Joseph, Lucas J Witer, Gregory R Jackson
A 60-year-old man presented with heart failure symptoms and was found to have a calcified pericardial effusion consistent with "milk of calcium" and constrictive physiology. The patient received a pericardiectomy and has had favorable outcomes at his 1-year follow-up. There are minimal reports of calcific pericardial effusion with constrictive pathology.
December 20, 2023: JACC. Case reports
https://read.qxmd.com/read/38179471/cardiac-tamponade-associated-with-primary-myelofibrosis-a-case-report
#32
Wishnu Aditya Widodo, Teuku Muhammad Haykal Putra, Maria Elfiana, Eka Widya Khorinal
BACKGROUND: Cardiac tamponade is a life-threatening condition that occurs when an abnormal amount of fluid accumulates in the pericardial sac and impedes the cardiac filling process. Although extremely rare, haematological diseases have the potential to trigger an extramedullary haematopoiesis (EMH) process within the pericardium, resulting in a substantial build-up of pericardial effusion. CASE SUMMARY: We present the case of a 29-year-old male previously diagnosed with primary myelofibrosis (PMF), who presented to the emergency unit with cardiac tamponade...
January 2024: European Heart Journal. Case Reports
https://read.qxmd.com/read/38140998/-an-exemplificative-case-of-constrictive-pericarditis
#33
JOURNAL ARTICLE
Ciro Pollio Benvenuto, Gabriella Locorotondo, Antonio Maria Leone
Constrictive pericarditis is a rare, but fatal disease, leading to heart failure due to diastolic dysfunction resulting from the fibrotic and non-elastic pericardium. Clinical presentation is sneaky, with initial symptoms of splanchnic and peripheral venous congestion, then with hepatomegaly and ascites: this kind of presentation is not often recognized, delaying diagnosis. We report the case of a young male adult with no previous cardiovascular history, but with a diagnosis of hepatic cirrhosis: investigations in our Centre led to the diagnosis of constrictive pericarditis, successfully treated with pericardiectomy; however, despite the effective venous decongestion, it was not possible to spare the patient from liver transplant...
January 2024: Giornale Italiano di Cardiologia
https://read.qxmd.com/read/38125117/retracted-the-clinical-efficacy-of-cedilanid-and-isosorbide-dinitrate-plus-pericardial-dissection-for-chronic-constrictive-pericarditis-in-the-elderly-and-its-influence-on-plasma-endothelin-atrial-natriuretic-peptide-and-systemic-immune-inflammation-index
#34
Evidence-Based Complementary And Alternative Medicine
[This retracts the article DOI: 10.1155/2022/5406649.].
2023: Evidence-based Complementary and Alternative Medicine: ECAM
https://read.qxmd.com/read/38116000/mulibrey-nanism-and-immunological-complications-a-comprehensive-case-report-and-literature-review
#35
REVIEW
Andrea Gazzin, Francesca Pala, Marita Bosticardo, Julie Niemela, Jennifer Stoddard, Eleonora Biasin, Paola Quarello, Diana Carli, Francesca Ferroni, Ottavia M Delmonte, Davide Montin, Sergio D Rosenzweig, Francesco Licciardi, Luigi D Notarangelo
INTRODUCTION: Mulibrey nanism (MUL) is a rare disorder caused by TRIM37 gene variants characterized by growth failure, dysmorphic features, congestive heart failure (CHF), and an increased risk of Wilms' tumor. Although immune system impairment has been documented in MUL, the underlying mechanisms remain poorly understood. METHODS: We present a case of MUL with progressive lymphopenia and review similar cases from the literature. RESULTS: Our patient presented with prenatal onset growth restriction, characteristic dysmorphic features, and Wilms' tumor...
2023: Frontiers in Immunology
https://read.qxmd.com/read/38077408/pericardial-infiltration-and-constriction-due-to-cardiac-actinomycosis-case-report
#36
Niloufar Korkchi, Linh Ngo, Kwun M Fong, Alex Chaudhuri, David Godbolt, Isuru Ranasinghe
BACKGROUND: Constrictive pericarditis associated with actinomycosis infection is a rare and challenging diagnosis due to its insidious manifestation. We describe the successful treatment of pericardial infiltration and constriction due to actinomycosis. CASE SUMMARY: A 50-year-old Aboriginal man presented with insidious onset of fatigue, dyspnoea, pleuritic chest pain, fever, drenching sweats, severe exercise intolerance to 50 m, and recurrent itchy skin lesions over 8 months...
November 2023: European Heart Journal. Case Reports
https://read.qxmd.com/read/38048190/constrictive-pericarditis
#37
JOURNAL ARTICLE
Meghan Nahass, John Kassotis
New England Journal of Medicine, Volume 389, Issue 22, Page 2087-2087, November 2023.
November 30, 2023: New England Journal of Medicine
https://read.qxmd.com/read/38046233/-imagen-multimodal-de-la-pericarditis-constrictiva-reporte-de-un-caso-de-cirrosis-cardiaca
#38
Lucía Barriales-Revilla, Lindsay Benites-Yshpilco, Roberto Baltodano-Arellano, Luis Falcón-Quispe, Kelly Cupe-Chacalcaje, Angela Cachicatari-Beltrán, Gerald Lévano-Pachas
Constrictive pericarditis is a rare cause of ascites and cardiac cirrhosis. We present the case of a 36-year-old male patient with a history of cirrhosis of unknown etiology, who consulted for refractory ascites, dyspnea, and lower limb swelling. Echocardiography determined constrictive pericarditis, which was corroborated by the findings of computed tomography. The clinical and hemodynamic worsening of the patient led to an emergency pericardiectomy with satisfactory recovery. This report shows a severe clinical consequence of constrictive pericarditis, cardiac cirrhosis, which was reversible with pericardial extirpation...
2023: Arch Peru Cardiol Cir Cardiovasc
https://read.qxmd.com/read/38032588/deep-learning-constrictive-pericarditis-and-its-occasional-doppelganger-a-step-closer-to-clinical-realization
#39
EDITORIAL
Brian D Hoit
No abstract text is available yet for this article.
November 15, 2023: JACC. Cardiovascular Imaging
https://read.qxmd.com/read/38025132/a-case-report-of-constrictive-pericarditis-following-covid-19-vaccination
#40
Eric Bain, Maya Guglin
BACKGROUND: COVID-19 infection and the COVID-19 vaccines have been associated with rare cases of pericarditis. We present a case of constrictive pericarditis (CP) following the vaccine. CASE SUMMARY: A 19-year-old healthy male started having progressive abdominal pain, emesis, dyspnoea, and pleuritic chest pain 2 weeks after the second dose of Pfizer vaccine. Computed tomography angiography chest revealed bilateral pleural effusions and pericardial thickening with effusion...
November 2023: European Heart Journal. Case Reports
keyword
keyword
61505
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.